CLINICAL_TRIALS
trial_result
· 2022-10-19
Clinical Trial Update: Phase 3 Alogliptin Pediatric Study [Phase 3]
Summary
Phase 3 pediatric study of alogliptin for type 2 diabetes has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2022-10-19